COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,786 Articles (22,946 medRxiv, 8,840 bioRxiv)

Most recent first Previous |  Page 1459: Articles 14581-14590  | Next

RT-LAMP has high accuracy for detecting SARS-CoV-2 in saliva and naso/oropharyngeal swabs from asymptomatic and symptomatic individuals
Kidd, S. P., Burns, D., Armson, B., Beggs, A. D., Howson, E. L. A., Williams, A. P., Snell, G., Wise, E. L., Goring, A., Vincent-Mistiaen, Z., Grippon, S., Sawyer, J., Cassar, C., Cross, D., Lewis, T., Reid, S. M., Rivers, S., James, J., Skinner, P., Davies, K., Ptasinska, A., Whalley, C., Poxen, C., Bosworth, A., Kidd, M., Machin, N., Richter, A., Burton, J., Love, H., Fouch, S., Patrick, H., Moore, N., Andreou, M., Laxman, S., Morant, N., Clark, D., Walsh, C., Houghton, R., Parker, J., Slater-Jefferies, J., Brown, I., Deans, Z., Porter, D., Cortes, N. J., Godfrey, K. M., Douglas, A., Hill, S. L., Fowler, V. L.
10.1101/2021.06.28.21259398 — Posted: 2021-07-03
PERFORMANCE AND UTILITY OF AN ORAL FLUID-BASED RAPID POINT-OF-CARE TEST FOR SARS-COV-2 ANTIBODY RESPONSE FOLLOWING COVID-19 INFECTION OR VACCINATION
Rao, P. V., Nair-Schaef, D., Chen, S., Kazmierczak, S. C., Roberts, C. T., Nagalla, S. R.
10.1101/2021.06.28.21259657 — Posted: 2021-07-03
An increased ratio of SARS-CoV-2 positive to negative sense genomic and subgenomic RNAs within routine diagnostic upper respiratory tract swabs may be a marker of virion shedding
Chamings, A., Bhatta, T. R., Alexandersen, S.
10.1101/2021.06.29.21259511 — Posted: 2021-07-03
Clinicogenomic analysis of breakthrough infections by SARS CoV2 variants after ChAdOx1 nCoV- 19 vaccination in healthcare workers
Kale, P., Gupta, E., Bihari, C., Patel, N., Rooge, S., Pandey, A., Bajpai, M., Khillan, V., Chattopadhyay, P. C., Devi, P., Maurya, R., Jha, N., Mehta, P., Kumar, M., Sharma, P., Saifi, S., S, A., Alam, S., Uppili, B., Faruq, M., Agrawal, A., Pandey, R., Sarin, S. K.
10.1101/2021.06.28.21259546 — Posted: 2021-07-03
Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people
Whitaker, M., Elliott, J., Chadeau-Hyam, M., Riley, S., Darzi, A., Cooke, G., Ward, H., Elliott, P.
10.1101/2021.06.28.21259452 — Posted: 2021-07-03 Discussion: Offsite
The SARS-CoV-2 receptor-binding domain expressed in Pichia pastoris as a candidate vaccine antigen
Limonta-Fernandez, M., Chinea-Santiago, G., Martin-Dunn, A. M., Gonzalez-Roche, D., Bequet-Romero, M., Marquez-Perera, G., Gonzalez-Moya, I., Canaan-Haden-Ayala, C., Cabrales-Rico, A., Espinosa-Rodriguez, L. A., Ramos-Gomez, Y., Andujar-Martinez, I., Gonzalez-Lopez, L. J., Perez de la Iglesia, M., Zamora-Sanchez, J., Cruz-Sui, O., Lemos-Perez, G., Cabrera-Herrera, G., Valdes-Hernandez, J., Martinez-Diaz, E., Pimentel-Vazquez, E., Ayala-Avila, M., Guillen-Nieto, G.
10.1101/2021.06.29.21259605 — Posted: 2021-07-03
BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure; Analysis of Household Members of COVID-19 Patients
Gazit, S., Mizrahi, B., Kalkstein, N., Neuberger, A., Peretz, A., Mizrahi-Reuveni, M., Patalon, T.
10.1101/2021.06.29.21259579 — Posted: 2021-07-03
Neuropsychiatric disorders as risk factors and consequences of COVID-19: A Mendelian randomization study
XIANG, Y., QIU, J., ZHANG, R., CHAU, C. K.-L., RAO, S., SO, H.-C.
10.1101/2021.06.29.21259609 — Posted: 2021-07-03
Uptake of SARS-CoV-2 workplace testing programs, March 2020 to March 2021
Duarte, N., D'Mello, S., Duarte, N. A., Rocco, S., Van Wyk, J., Pillai, A. A., Liu, M., Williamson, T., Arora, R. K.
10.1101/2021.06.29.21259730 — Posted: 2021-07-03
A national survey of attitudes towards and intentions to vaccinate against COVID-19: implications for communications
Stead, M., Jessop, C., Angus, K., Bedford, H., Ussher, M., Ford, A., Eadie, D., MacGregor, A., Hunt, K., MacKintosh, A. M.
10.1101/2021.06.29.21259717 — Posted: 2021-07-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).